Remove 2025 Remove Clinical Trials Remove Conditions Remove Media
article thumbnail

MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan

Cannabis Law Report

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. Media: media@mymd.com. in the blood. 646) 421-9523.

article thumbnail

Where Does The FDA Stand on CBD and CBD Products?

The Joint Blog

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. organic food market by 2025 is at $70.4 Cannabis has come a long way from being the taboo herb of decades past. CBD is everywhere these days. It has been predicted that the U.S CBD Products and the FDA The U.S.

CBD 33
article thumbnail

Medical Cannabis Company Sunshine Coast Tikun Oceana, formerly known as Medifarm Calls In The Administrators

Cannabis Law Report

Sunshine Coast based Tikun Oceana, formerly known as Medifarm , is now under the control of administrators from Cor Cordis.The company was founded …… Predictably Murdoch media has this behind a paywall if you want to pay to learn more. Different strains for different conditions. Read more at. ABC report 9 January 2018.